Literature DB >> 9514624

The use of bronchodilators in stable chronic obstructive pulmonary disease.

M Cazzola1, D Spina, M G Matera.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9514624     DOI: 10.1006/pupt.1997.0087

Source DB:  PubMed          Journal:  Pulm Pharmacol Ther        ISSN: 1094-5539            Impact factor:   3.410


× No keyword cloud information.
  6 in total

Review 1.  Long acting beta(2) agonists and theophylline in stable chronic obstructive pulmonary disease.

Authors:  M Cazzola; C F Donner; M G Matera
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

Review 2.  β(2) -adrenoceptor agonists: current and future direction.

Authors:  Mario Cazzola; Luigino Calzetta; Maria Gabriella Matera
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

3.  Acute effect of pretreatment with single conventional dose of salmeterol on dose-response curve to oxitropium bromide in chronic obstructive pulmonary disease.

Authors:  M Cazzola; F Di Perna; S Centanni; C Califano; C F Donner; M D'Amato; G D'Amato
Journal:  Thorax       Date:  1999-12       Impact factor: 9.139

Review 4.  Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.

Authors:  M Cazzola; C F Donner
Journal:  Drugs       Date:  2000-08       Impact factor: 9.546

5.  Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.

Authors:  Richard Hodder; Steven Kesten; Shailendra Menjoge; Klaus Viel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

Review 6.  Striving for optimal bronchodilation: focus on olodaterol.

Authors:  Cristoforo Incorvaia; Marcello Montagni; Elena Makri; Gian Galeazzo Riario-Sforza; Erminia Ridolo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-03-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.